Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 15 studies | 25% ± 7% | |
brain | 10 studies | 31% ± 17% | |
lung | 6 studies | 20% ± 3% | |
bone marrow | 4 studies | 20% ± 3% | |
heart | 4 studies | 18% ± 2% | |
lymph node | 4 studies | 22% ± 5% | |
adipose | 4 studies | 20% ± 3% | |
intestine | 3 studies | 21% ± 7% | |
liver | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5226.64 | 1445 / 1445 | 100% | 20.54 | 183 / 183 |
intestine | 100% | 4753.11 | 966 / 966 | 100% | 27.08 | 527 / 527 |
kidney | 100% | 3350.67 | 89 / 89 | 100% | 26.35 | 901 / 901 |
ovary | 100% | 5166.65 | 180 / 180 | 100% | 24.30 | 430 / 430 |
prostate | 100% | 5581.21 | 245 / 245 | 100% | 32.54 | 502 / 502 |
stomach | 100% | 3099.36 | 359 / 359 | 100% | 22.82 | 286 / 286 |
thymus | 100% | 4581.98 | 653 / 653 | 100% | 42.31 | 605 / 605 |
uterus | 100% | 5808.99 | 170 / 170 | 100% | 36.23 | 459 / 459 |
skin | 100% | 4477.70 | 1808 / 1809 | 100% | 38.90 | 472 / 472 |
breast | 100% | 4138.51 | 459 / 459 | 100% | 36.81 | 1117 / 1118 |
lung | 100% | 5342.74 | 577 / 578 | 100% | 28.94 | 1155 / 1155 |
brain | 100% | 3757.29 | 2637 / 2642 | 100% | 32.28 | 705 / 705 |
bladder | 100% | 4904.29 | 21 / 21 | 100% | 27.46 | 503 / 504 |
adrenal gland | 100% | 3193.71 | 258 / 258 | 100% | 24.89 | 229 / 230 |
pancreas | 99% | 1630.50 | 324 / 328 | 99% | 31.02 | 177 / 178 |
liver | 100% | 1911.56 | 226 / 226 | 98% | 13.51 | 398 / 406 |
adipose | 100% | 4377.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 47.78 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.82 | 29 / 29 |
spleen | 100% | 6966.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 36.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.92 | 1 / 1 |
blood vessel | 100% | 3481.03 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 6237.79 | 928 / 929 | 0% | 0 | 0 / 0 |
heart | 100% | 2916.45 | 859 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 2705.69 | 798 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0071339 | Cellular component | MLL1 complex |
GO_0070443 | Cellular component | Mad-Max complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0071943 | Cellular component | Myc-Max complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0070888 | Molecular function | E-box binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MAX |
Protein name | Protein max (Myc-associated factor X) Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X) MYC associated factor X |
Synonyms | BHLHD4 hCG_41671 |
Description | FUNCTION: Transcription regulator. Forms a sequence-specific DNA-binding protein complex with MYC or MAD which recognizes the core sequence 5'-CAC[GA]TG-3'. The MYC:MAX complex is a transcriptional activator, whereas the MAD:MAX complex is a repressor. May repress transcription via the recruitment of a chromatin remodeling complex containing H3 'Lys-9' histone methyltransferase activity. Represses MYC transcriptional activity from E-box elements. . |
Accessions | ENST00000557746.5 ENST00000394606.6 [P61244-3] ENST00000555932.5 G3V563 Q6V3B1 ENST00000555667.5 G3V570 ENST00000553928.5 [P61244-3] ENST00000358664.9 [P61244-1] ENST00000246163.2 [P61244-5] ENST00000557277.5 ENST00000651648.1 ENST00000556443.5 ENST00000284165.10 [P61244-4] ENST00000556892.6 A0A494C130 ENST00000556979.6 [P61244-3] ENST00000555419.5 G3V2N4 Q8IYC6 P61244 Q8TAX8 ENST00000341653.6 [P61244-6] G3V2R5 ENST00000358402.8 [P61244-2] G3V302 G3V5L1 |